Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Radotinib> ?p ?o }
Showing triples 1 to 66 of
66
with 100 triples per page.
- Radotinib abstract "Radotinib (INN; trade name Supect), and sometimes referred to by its investigational name IY5511, is a drug for the treatment of different types of cancer, most notably Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) with resistance or intolerance of other tyrosine kinase Bcr-Abl inhibitors, such as patients resistant or intolerant to the drug Imatinib (Gleevec, Glivec). Radotinib is being developed by Ilyang Pharmaceutical Co., Ltd of South Korea and is co-marketed by Daewoong Pharmaceutical Co. Ltd, in South Korea. Radotinib completed a multi-national Phase II clinical trial study in 2012 and in August 2011, Ilyang initiated a Phase III, multinational, multi-center, open-label, randomized study for first-line indication. Its mechanism of action involves inhibition of the tyrosine kinase Bcr-Abl and of platelet-derived growth factor receptor (PDGFR).".
- Radotinib casNumber "926037-48-1".
- Radotinib iupacName "4-Methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyrazin-2-ylpyrimidin-2-yl)amino]benzamide".
- Radotinib pubchem "16063245".
- Radotinib thumbnail Radotinib.svg?width=300.
- Radotinib wikiPageID "40955419".
- Radotinib wikiPageLength "3949".
- Radotinib wikiPageOutDegree "15".
- Radotinib wikiPageRevisionID "644948003".
- Radotinib wikiPageWikiLink Bcr-Abl.
- Radotinib wikiPageWikiLink Category:Benzamides.
- Radotinib wikiPageWikiLink Category:Imidazoles.
- Radotinib wikiPageWikiLink Category:Pyrazines.
- Radotinib wikiPageWikiLink Category:Pyrimidines.
- Radotinib wikiPageWikiLink Category:Tyrosine_kinase_inhibitors.
- Radotinib wikiPageWikiLink Chronic_myelogenous_leukemia.
- Radotinib wikiPageWikiLink Chronic_myeloid_leukemia.
- Radotinib wikiPageWikiLink Imatinib.
- Radotinib wikiPageWikiLink International_Nonproprietary_Name.
- Radotinib wikiPageWikiLink Mechanism_of_action.
- Radotinib wikiPageWikiLink Philadelphia_chromosome.
- Radotinib wikiPageWikiLink Platelet-derived_growth_factor_receptor.
- Radotinib wikiPageWikiLink Tyrosine_kinase.
- Radotinib wikiPageWikiLinkText "Radotinib".
- Radotinib wikiPageWikiLinkText "radotinib".
- Radotinib c "27".
- Radotinib casNumber "926037".
- Radotinib chemspiderid "17222861".
- Radotinib f "3".
- Radotinib h "21".
- Radotinib hasPhotoCollection Radotinib.
- Radotinib inchi "1".
- Radotinib inchikey "DUPWHXBITIZIKZ-UHFFFAOYAF".
- Radotinib iupacName "4".
- Radotinib molecularWeight "530.5".
- Radotinib n "8".
- Radotinib o "1".
- Radotinib pubchem "16063245".
- Radotinib smiles "CC1=CNC4=NC=CCC5=NC=CN=C5".
- Radotinib stdinchi "1".
- Radotinib stdinchikey "DUPWHXBITIZIKZ-UHFFFAOYSA-N".
- Radotinib tradename "Supect".
- Radotinib wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- Radotinib wikiPageUsesTemplate Template:Drugbox.
- Radotinib wikiPageUsesTemplate Template:Reflist.
- Radotinib subject Category:Benzamides.
- Radotinib subject Category:Imidazoles.
- Radotinib subject Category:Pyrazines.
- Radotinib subject Category:Pyrimidines.
- Radotinib subject Category:Tyrosine_kinase_inhibitors.
- Radotinib hypernym Drug.
- Radotinib type ChemicalSubstance.
- Radotinib type Drug.
- Radotinib type ChemicalObject.
- Radotinib type Thing.
- Radotinib type Q8386.
- Radotinib comment "Radotinib (INN; trade name Supect), and sometimes referred to by its investigational name IY5511, is a drug for the treatment of different types of cancer, most notably Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) with resistance or intolerance of other tyrosine kinase Bcr-Abl inhibitors, such as patients resistant or intolerant to the drug Imatinib (Gleevec, Glivec).".
- Radotinib label "Radotinib".
- Radotinib sameAs m.0yw_033.
- Radotinib sameAs Radotinib.
- Radotinib sameAs Radotinib.
- Radotinib sameAs Q15269680.
- Radotinib sameAs Q15269680.
- Radotinib wasDerivedFrom Radotinib?oldid=644948003.
- Radotinib depiction Radotinib.svg.
- Radotinib isPrimaryTopicOf Radotinib.